MRPL42 Knockdown通过调节氧化酸化抑制肝细胞癌的恶性功能

Jun Lv1, Fu-Yuan Gan2, Ming-Hao Li2

  • 1Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China. lvjun1996@163.com.

PubMed
概括

线粒体核糖体蛋白L42 (MRPL42) 在肝细胞癌 (HCC) 中过度表达,导致瘤生长. 针对MRPL42及其对氧化酸化 (OXPHOS) 的调节,显示出HCC诊断和治疗的潜力.